BRPI0911543A2 - arilciclopentenos substituídos como agentes terapêuticos - Google Patents
arilciclopentenos substituídos como agentes terapêuticosInfo
- Publication number
- BRPI0911543A2 BRPI0911543A2 BRPI0911543A BRPI0911543A BRPI0911543A2 BR PI0911543 A2 BRPI0911543 A2 BR PI0911543A2 BR PI0911543 A BRPI0911543 A BR PI0911543A BR PI0911543 A BRPI0911543 A BR PI0911543A BR PI0911543 A2 BRPI0911543 A2 BR PI0911543A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic agents
- arylcyclopentenes
- substituted
- substituted arylcyclopentenes
- therapeutic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
- C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4760908P | 2008-04-24 | 2008-04-24 | |
| PCT/US2009/041394 WO2009132093A2 (en) | 2008-04-24 | 2009-04-22 | Substituted arylcyclopentenes as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0911543A2 true BRPI0911543A2 (pt) | 2015-10-13 |
Family
ID=40886981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0911543A BRPI0911543A2 (pt) | 2008-04-24 | 2009-04-22 | arilciclopentenos substituídos como agentes terapêuticos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7803797B2 (pt) |
| EP (1) | EP2297085B1 (pt) |
| AU (1) | AU2009239377B2 (pt) |
| BR (1) | BRPI0911543A2 (pt) |
| CA (1) | CA2722403C (pt) |
| ES (1) | ES2735217T3 (pt) |
| WO (1) | WO2009132093A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008207991B9 (en) * | 2007-01-22 | 2014-02-27 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
| EP2288598B1 (en) * | 2008-04-24 | 2012-03-21 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8329559D0 (en) * | 1983-11-04 | 1983-12-07 | Erba Farmitalia | Furyl derivatives of 16-substituted prostaglandins preparations |
| US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
| US5476872A (en) | 1993-10-18 | 1995-12-19 | Allergan, Inc. | 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1 |
| US5462968A (en) | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5698598A (en) | 1995-08-04 | 1997-12-16 | Allergan | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US20020094981A1 (en) * | 1997-05-30 | 2002-07-18 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
| US6090847A (en) | 1997-11-21 | 2000-07-18 | Allergan Sales, Inc. | EP2 -receptor agonists as neuroprotective agents for the eye |
| US6437146B1 (en) | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| BR0213911A (pt) | 2001-11-05 | 2004-09-28 | Allergan Inc | Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2 |
| US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| BRPI0605926A2 (pt) * | 2005-01-14 | 2009-05-26 | Allergan Inc | ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos |
| US7868035B2 (en) * | 2005-02-01 | 2011-01-11 | Allergan, Inc. | Therapeutic esters |
| WO2007115020A2 (en) * | 2006-04-04 | 2007-10-11 | Allergan, Inc. | Therapeutic prostaglandin compounds for the treatment of glaucoma |
| US20070254920A1 (en) * | 2006-04-26 | 2007-11-01 | Aerie Pharmaceuticals, Inc. | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| EP2046714B1 (en) * | 2006-06-20 | 2015-12-09 | Allergan, Inc. | Cyclopentane derivatives as antiglaucoma agents |
| WO2008041054A1 (en) * | 2006-10-02 | 2008-04-10 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| US7507817B2 (en) * | 2006-11-17 | 2009-03-24 | Allergan, Inc. | Prostaglandin prodrugs |
| AU2008207991B9 (en) * | 2007-01-22 | 2014-02-27 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
| EP2288598B1 (en) * | 2008-04-24 | 2012-03-21 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
-
2009
- 2009-04-22 WO PCT/US2009/041394 patent/WO2009132093A2/en not_active Ceased
- 2009-04-22 CA CA2722403A patent/CA2722403C/en active Active
- 2009-04-22 BR BRPI0911543A patent/BRPI0911543A2/pt not_active IP Right Cessation
- 2009-04-22 EP EP09735684.4A patent/EP2297085B1/en not_active Not-in-force
- 2009-04-22 US US12/427,803 patent/US7803797B2/en not_active Expired - Fee Related
- 2009-04-22 ES ES09735684T patent/ES2735217T3/es active Active
- 2009-04-22 AU AU2009239377A patent/AU2009239377B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20090270385A1 (en) | 2009-10-29 |
| EP2297085B1 (en) | 2019-03-20 |
| WO2009132093A2 (en) | 2009-10-29 |
| CA2722403A1 (en) | 2009-10-29 |
| ES2735217T3 (es) | 2019-12-17 |
| EP2297085A2 (en) | 2011-03-23 |
| WO2009132093A3 (en) | 2009-12-17 |
| AU2009239377A1 (en) | 2009-10-29 |
| AU2009239377B2 (en) | 2014-05-01 |
| US7803797B2 (en) | 2010-09-28 |
| CA2722403C (en) | 2017-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| BRPI0922845A2 (pt) | pirazol-4-n-alcoxicarboxamidas como microbiocidas | |
| SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
| BRPI0911347A2 (pt) | gama lactamas substituídas como agentes terapêuticos | |
| EP2320907A4 (en) | THERAPEUTIC COMPOUNDS | |
| BRPI0919295A2 (pt) | 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios. | |
| EP2296593A4 (en) | MEDICAL HEAD COVER | |
| CR10926A (es) | Nuevas 2-aminooxazolinas como ligandos taar1 | |
| EP2268285A4 (en) | THERAPEUTIC COMPOUNDS | |
| DK2326651T3 (da) | Buprenorphinanaloger | |
| EP2351595A4 (en) | Medical connection | |
| DK2144905T3 (da) | Terapeutiske midler | |
| DK3300729T3 (da) | Terapeutiske sammensætninger indeholdende macitentan | |
| BRPI0910534A2 (pt) | terapia antiviral | |
| LT3150178T (lt) | Stimuliavimo aparatas | |
| BRPI0920743A2 (pt) | ribonucleases terapeuticas | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| SMT201600041B (it) | Agenti terapeutici 713 | |
| DK2379722T3 (da) | Ekspressionsvektor | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| EP2427183A4 (en) | THERAPEUTIC COMPOUNDS | |
| HRP20160577T1 (hr) | Liječenje osteoartritisa | |
| BRPI0910931A2 (pt) | ciclopentanos substituídos terapêuticos | |
| BRPI0910991A2 (pt) | piperidinas substituídas como compostos terapêuticos | |
| BRPI0918062A2 (pt) | Tienilaminopirimidinas como fungicidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |